Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
Liver metastases are the most common site of metastatic spread in colorectal cancer. Current treatment approaches involve effective systemic therapies in combination with surgical and/or interventional strategies. Multimodal strategies greatly improved clinical outcomes of patients with metastatic c...
Guardado en:
Autores principales: | Carolin Czauderna, Kim Luley, Nikolas von Bubnoff, Jens U. Marquardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de919e8f156747908800041d56b6a7c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Sternschuss Michal, et al.
Publicado: (2021) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Alvaro Gutierrez, et al.
Publicado: (2021) -
Differential Expression of the Sphingolipid Pathway Is Associated with Sensitivity to the PP2A Activator FTY720 in Colorectal Cancer Cell Lines
por: Peter Sciberras, et al.
Publicado: (2021) -
Liver Transplantation for Non-Resectable Colorectal Liver Metastases
por: Ashwin Rammohan
Publicado: (2018) -
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
por: Chengwen Zhao, et al.
Publicado: (2021)